Risk factors for cancer of the uterine cervix in Propriá, Sergipe, Brazil;Fatores associados ao câncer do colo uterino em Propriá, Sergipe, Brasil

Cadernos de Saude Publica

Volumn 22, Issue 10, 2006, Pages 2151-2156

  Lima, Carlos Anselmo ^a,b   Palmeira, José Arnaldo Vasconcelos ^a   Cipolotti, Rosana ^a,b  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b Hospital Governador João Alves Filho   (Brazil)

Author keywords

Cervix neoplasms; Citology; Papillomavirus; Vaginal smears

Indexed keywords

EID: 33749553087     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/s0102-311x2006001000021     Document Type: Article

References (14)

1. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implication for prevention and projections of future burden. Int J Cancer 1993; 55:891-3.
2. Coordenação de Prevenção e Vigilância, Instituto Nacional de Câncer. Estimativa 2005: incidência de câncer no Brasil. Rio de Janeiro: Instituto Nacional de Câncer; 2004.
3. Cavalcanti SMB, Deus FCC, Zardo LG, Frugulhetti ICPP, Oliveira LHS. Human papillomavirus infection and cervical câncer in Brazil: a retrospective study. Mem Inst Oswaldo Cruz 1996; 91:433-40.
4. Muñoz N, Bosch FX, De Sanjosé S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518-27.
5. Hammouda D, Munoz N, Herrero R, Arslan A, Bouhadef A, Oublil M, et al. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer 2005; 113:483-9.
6. Berrington-de-Gonzalez A, Sweetland S, Green J. Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis. Br J Cancer 2004; 90:1787-91.
7. Runowicz CD, Fields AL. Screening for gynecoplogic malignancies: a continuing responsibility. Surg Oncol Clin N Am 1999; 8:703-23.
8. Gopalkrishna V, Murthy NS, Sharma JK, Roy M, Das DK, Luthra UK, et al. Increased human papillomavirus infection with the increasing number of pregnancies in Indian women. J Infect Dis 1995; 171:254-5.
9. Ledwaba T, Dlamini Z, Naicker S, Bhoola K. Molecular genetics of human cervical cancer: role of papillomavirus and the apoptotic cascade. Biol Chem 2004; 385:671-82.
10. Holschneider CH, Baldwin RL, Tumber K, Aoyama C, Karlan BY. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer. Clin Cancer Res. 2005; 11:5756-63.
11. Bekkers RL, Massuger LF, Bulten J, Melchers WJ. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev Med Virol 2004; 14:95-105.
12. Orr Jr. JW. Cervical cancer. Surg Oncol Clin N Am 1998; 7:299-316.
13. Palaoro LA, Szulc M, Giogrande JC, Bariandaran P. Cells with dyskeratotic inclusions in smears from cervix uteri infected by human papillomavirus. Rev Bras Cancerol 1999; 45:9-13.
14. Mitchell JB, McCormack LA. Time trends in late-stage diagnosis of cervical cancer. Differences by race/ethnicity and income. Med Care 1997; 12:1220-4.